Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?

por Andersson, Sonia, Belkić, Karen, Mints, Miriam, Östensson, Ellinor
Publicado 2018

Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education

por Andersson, Sonia, Belkić, Karen, Mints, Miriam, Östensson, Ellinor
Publicado 2019

Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia

por Östensson, Ellinor, Belkić, Karen, Ramqvist, Torbjörn, Mints, Miriam, Andersson, Sonia
Publicado 2021

Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow-up

por Belkić, Karen, Andersson, Sonia, Alder, Susanna, Mints, Miriam, Megyessi, David
Publicado 2022

Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge

por Andersson, Sonia, Belkić, Karen, Demirbüker, Selin Safer, Mints, Miriam, Östensson, Ellinor
Publicado 2017

Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment

por Andersson, Sonia, Megyessi, David, Belkić, Karen, Alder, Susanna, Östensson, Ellinor, Mints, Miriam
Publicado 2021